• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 17 Nov 2022

    Pharma companies target niche segments in the US, as India business grows

    buy
    Pharmaceuticals & Biotech.
    by Trendlyne Analysis
    Trendlyne Analysis
    Indian drug formulation companies are adapting to the fast-changing dynamics of the
    pharma industry. Top-listed players have been making their bets and changing the pattern of their capital allocation in the past two years.
    Copy Link Share on Share on Share on Share on
    Alert  
    More from Pharmaceuticals & Biotech.
    Recommended
    Five stocks to buy from analysts this week - September 9, 2025
    The Baseline | 09 Sep 2025, 05:38PM
    Market closes higher, Waaree Renewable bags a Rs 1,252 crore solar project
    Trendlyne Marketwatch | 09 Sep 2025, 04:00PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd